제10회 대한폐고혈압학회 학술대회
July 11-12, 2025
Coex Magok, Seoul, Korea
1999 – 2005 Bachelor degree from Keimyung University, School of Medicine, Daegu, Korea
2006 – 2008 Master of Science from Keimyung University, Graduate School, Daegu, Korea
2009 – 2014 Ph.D. degree from Keimyung University, Graduate School, Daegu, Korea
2016.3 ~ 2017.2 Assistant Professor, Division of Cardiology, Severance Cardiovascular Hospital
2017.3 ~ 2021.2 Assistant Professor, Keimyung University Dongsan Hospital
2022.7 ~ 2023.7 Visiting Professor, Heart Transplant Program, Smidt Heart Institute Cedars-Sinai Medical Center, Los Angeles, California
2021.3 ~ Present Associate Professor, Keimyung University Dongsan Hospital
Heart Failure
Echocardiography
Pulmonary Hypertension
Hypertension
Transplantation
Ten-year follow-up cohort of the everolimus versus azathioprine multinational prospective study focusing on intravascular ultrasound findings. J Heart Lung Transplant. 2024
Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation. JACC Heart Fail. 2024 Feb;12(2):395-405
Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy. Sci Rep. 2022 May 11;12(1)
M.D., School of Chinese Medicine (double major in Medicine), China Medical University, Taichung, Taiwan
M.Sc., Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan
Ph.D., Bristol Heart Institute, University of Bristol, Bristol, United Kingdom
2006- Senior Consultant Cardiologist, Department of Cardiovascular Medicine, MacKay Memorial Hospital, Taipei, Taiwan
2016-2023 Chair, Department of Medicine, MacKay Medical College, New Taipei, Taiwan
2016-2023 Chief, Department of Medical Education, MacKay Memorial Hospital, Taipei, Taiwan
2024- High Commissioner, Superintendent Office, MacKay Memorial Hospital, Taipei, Taiwan
2024- Chief, Division of Preventive Cardiology & Pulmonary Circulation Medicine, Department of Cardiovascular Medicine, MacKay Memorial Hospital, Taipei, Taiwan
1. Vascular biology
2. Pulmonary hypertension
3. Endothelial progenitor cells
4. Medical education
1. Wu YJ, Bond M, Sala-Newby GB, Newby AC. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ Res 2006;98:1141-50.
2. Bond M*, Wu YJ*, Sala-Newby GB, Newby AC. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation and intima formation in vitro and in vivo. Cardiovasc Res 2008;80:290-8.
3. Wang HH, Lee YN, Su CH, Shu KT, Liu WT, Hsieh CL, Yeh HI, Wu YJ*. S-phase kinase-associated protein-2 rejuvenates senescent endothelial progenitor cells and induces angiogenesis in vivo. Sci Rep 2020;10(1):6646.
4. Lee YN, Wang HH, Su CH, Lee HI, Chou YH, Hsieh CL, Liu WT, Shu KT, Chang KT, Yeh HI, Wu YJ*. Deferoxamine accelerates endothelial progenitor cell senescence to compromise angiogenic activity. Aging 2021;13(17):21364-21384.
5. Chou YH, Lee YN, Su CH, Lee HI, Hsieh CL, Tien TY, Lin CF, Yeh HI, Wu YJ*. Senescence induces miR-409 to down-regulate CCL5 and impairs angiogenesis in endothelial progenitor cells. J Cell Mol Med 2024;24(12):e18489.